Is there diversity amongUGT1A1polymorphism in Japan

This publication has 33 references indexed in Scilit:

• Prospective Phase II Study of FOLFIRI for mCRC in Japan, Including the Analysis of UGT1A1*28/*6 Polymorphisms
  Japanese Journal of Clinical Oncology, 2011
• Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1*28 polymorphism
  Cancer Science, 2010
• Close Association of UGT1A9 IVS1+399C>T with UGT1A1*28, *6, or *60 Haplotype and Its Apparent Influence on 7-Ethyl-10-hydroxycamptothecin (SN-38) Glucuronidation in Japanese
  Drug Metabolism and Disposition, 2009
• colorectal cancer
  Annals of Oncology, 2008
• Gilbert's Syndrome and Irinotecan Toxicity: Combination with UDP-Glucuronosyltransferase 1A7 Variants Increases Risk
  Cancer Epidemiology, Biomarkers & Prevention, 2008
• UGT1A1Promoter Genotype Correlates With SN-38 Pharmacokinetics, but Not Severe Toxicity in Patients Receiving Low-Dose Irinotecan
  Journal of Clinical Oncology, 2007
• Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN‐38 glucuronidation in Japanese patients with cancer
  Cancer Science, 2006
• Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism predicts the risk of gastrointestinal toxicity and fatigue induced by irinotecan‐based chemotherapy
  Cancer, 2006
• RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
  Drug Metabolism and Disposition, 2005
• Approximate is Better than “Exact” for Interval Estimation of Binomial Proportions
  The American Statistician, 1998